{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T09:50:36Z","timestamp":1774432236902,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-025-04274-z","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T13:24:12Z","timestamp":1747401852000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mohs Micrographic Surgery (MMS) in immunosuppressed patients: a review of outcomes and prognosis"],"prefix":"10.1007","volume":"317","author":[{"given":"Maira A.","family":"Bhatty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micah","family":"Belzberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison T.","family":"Vidimos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Poblete-Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,16]]},"reference":[{"key":"4274_CR1","doi-asserted-by":"publisher","unstructured":"Heise ER (1982) Diseases associated with immunosuppression. Environ Health Perspect 43. https:\/\/doi.org\/10.1289\/ehp.82439","DOI":"10.1289\/ehp.82439"},{"key":"4274_CR2","doi-asserted-by":"publisher","unstructured":"Tam S, Gross ND (2019) Cutaneous squamous cell carcinoma in immunosuppressed patients. Curr Oncol Rep 21(9). https:\/\/doi.org\/10.1007\/s11912-019-0831-1","DOI":"10.1007\/s11912-019-0831-1"},{"key":"4274_CR3","doi-asserted-by":"publisher","unstructured":"Jensen P, Hansen S, Moller B et al (1999) Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 40(2 I). https:\/\/doi.org\/10.1016\/S0190-9622(99)70185-4","DOI":"10.1016\/S0190-9622(99)70185-4"},{"key":"4274_CR4","doi-asserted-by":"publisher","unstructured":"Martinson ML, Lapham J (2024) Prevalence of immunosuppression among US adults. JAMA 331(10). https:\/\/doi.org\/10.1001\/jama.2023.28019","DOI":"10.1001\/jama.2023.28019"},{"key":"4274_CR5","doi-asserted-by":"publisher","unstructured":"Connolly SM, Baker DR, Coldiron BM et al (2012) AAD\/ACMS\/ASDSA\/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: A report of the American academy of dermatology, American college of Mohs surgery, American society for dermatologic surgery association, and the American society for Mohs surgery. J Am Acad Dermatol 67(4). https:\/\/doi.org\/10.1016\/j.jaad.2012.06.009","DOI":"10.1016\/j.jaad.2012.06.009"},{"key":"4274_CR6","doi-asserted-by":"publisher","unstructured":"Collins L, Quinn A, Stasko T (2019) Skin Cancer and immunosuppression. Dermatol Clin 37(1). https:\/\/doi.org\/10.1016\/j.det.2018.07.009","DOI":"10.1016\/j.det.2018.07.009"},{"key":"4274_CR7","doi-asserted-by":"publisher","unstructured":"Song SS, Goldenberg A, Ortiz A, Eimpunth S, Oganesyan G, Jiang SIB (2016) Nonmelanoma skin cancer with aggressive subclinical extension in immunosuppressed patients. JAMA Dermatol 152(6). https:\/\/doi.org\/10.1001\/jamadermatol.2016.0192","DOI":"10.1001\/jamadermatol.2016.0192"},{"key":"4274_CR8","doi-asserted-by":"publisher","unstructured":"Goldenberg A, Ortiz A, Kim SS, Jiang SB (2015) Squamous cell carcinoma with aggressive subclinical extension: 5-Year retrospective review of diagnostic predictors. J Am Acad Dermatol 73(1). https:\/\/doi.org\/10.1016\/j.jaad.2015.02.1131","DOI":"10.1016\/j.jaad.2015.02.1131"},{"key":"4274_CR9","doi-asserted-by":"publisher","unstructured":"Canavan TN, Celen AB, Frazzette NJ, Carucci JA, Doudican N, Stevenson ML (2023) A cohort study to determine factors associated with upstaging cutaneous squamous cell carcinoma during Mohs surgery. J Am Acad Dermatol 88(1). https:\/\/doi.org\/10.1016\/j.jaad.2022.03.055","DOI":"10.1016\/j.jaad.2022.03.055"},{"key":"4274_CR10","doi-asserted-by":"publisher","unstructured":"Abril-P\u00e9rez C, Mansilla\u2010Polo M, Escutia\u2010Mu\u00f1oz B et al (2024) Mohs micrographic surgery in immunosuppressed vs immunocompetent patients: Results of a prospective nationwide cohort study (<\u2009scp\u2009>\u2009REGESMOHS, Spanish registry of Mohs surgery). Journal of the European Academy of Dermatology and Venereology. Published online May 11. https:\/\/doi.org\/10.1111\/jdv.20103","DOI":"10.1111\/jdv.20103"},{"key":"4274_CR11","doi-asserted-by":"publisher","unstructured":"Hamel RK, Phillipps J, Nisar T et al (2023) Operative expectations for Mohs surgery in patients with chronic lymphocytic leukemia: A multicenter retrospective cohort study. JAAD Int 11. https:\/\/doi.org\/10.1016\/j.jdin.2023.02.014","DOI":"10.1016\/j.jdin.2023.02.014"},{"key":"4274_CR12","doi-asserted-by":"publisher","unstructured":"Montero-Vilchez T, Garc\u00e9s JR, Rodr\u00edguez-Prieto MA et al (2023) Development and validation of a model to predict complex Mohs micrographic surgery in clinical practice: REGESMOSH scale. J Eur Acad Dermatol Venereol 37(8). https:\/\/doi.org\/10.1111\/jdv.19056","DOI":"10.1111\/jdv.19056"},{"key":"4274_CR13","doi-asserted-by":"publisher","unstructured":"Sonia Batra R, Kelley LC (2002) Predictors of extensive subclinical spread in nonmelanoma skin cancer treated with Mohs micrographic surgery. Arch Dermatol 138(8). https:\/\/doi.org\/10.1001\/archderm.138.8.1043","DOI":"10.1001\/archderm.138.8.1043"},{"key":"4274_CR14","doi-asserted-by":"publisher","unstructured":"Sahai S, Walling HW (2012) Factors predictive of complex Mohs surgery cases. J Dermatological Treat 23(6). https:\/\/doi.org\/10.3109\/09546634.2011.579083","DOI":"10.3109\/09546634.2011.579083"},{"key":"4274_CR15","doi-asserted-by":"publisher","unstructured":"Merritt BG, Lee NY, Brodland DG, Zitelli JA, Cook J (2012) The safety of Mohs surgery: A prospective multicenter cohort study. J Am Acad Dermatol 67(6). https:\/\/doi.org\/10.1016\/j.jaad.2012.05.041","DOI":"10.1016\/j.jaad.2012.05.041"},{"key":"4274_CR16","doi-asserted-by":"publisher","unstructured":"Tom\u00e1s-Vel\u00e1zquez A, Sanmartin-Jim\u00e9nez O, Garc\u00e9s JR et al (2021) Risk factors and rate of recurrence after Mohs surgery in basal cell and squamous cell carcinomas: A nationwide prospective cohort (REGESMOHS, Spanish registry of Mohs surgery). Acta Derm Venereol 101(11). https:\/\/doi.org\/10.2340\/ACTADV.V101.544","DOI":"10.2340\/ACTADV.V101.544"},{"key":"4274_CR17","doi-asserted-by":"publisher","unstructured":"Nash J, Shahwan KT, Carr DR (2023) Clinical practicality of reporting cutaneous squamous cell carcinoma risk factors at the time of Mohs surgery. Arch Dermatol Res 315(2). https:\/\/doi.org\/10.1007\/s00403-022-02376-6","DOI":"10.1007\/s00403-022-02376-6"},{"key":"4274_CR18","doi-asserted-by":"publisher","unstructured":"Basu P, Goldenberg A, Cowan N, Eilers R, Hau J, Jiang SIB (2019) A 4-year retrospective assessment of postoperative complications in immunosuppressed patients following Mohs micrographic surgery. J Am Acad Dermatol 80(6). https:\/\/doi.org\/10.1016\/j.jaad.2018.11.032","DOI":"10.1016\/j.jaad.2018.11.032"},{"key":"4274_CR19","doi-asserted-by":"publisher","unstructured":"Ruiz-Salas V, Sanmartin-Jim\u00e9nez O, Garc\u00e9s JR et al (2022) Complications associated with Mohs micrographic surgery: data from the nationwide prospective cohort REGESMOHS. Dermatology 238(2). https:\/\/doi.org\/10.1159\/000517010","DOI":"10.1159\/000517010"},{"key":"4274_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jdin.2024.07.016","volume":"17","author":"A Chen Yin Lua","year":"2024","unstructured":"Chen Yin Lua A, Ai Qun Oh D, See Tow HX, Por RH, Yi Koh H, Chiat Oh C (2024) Mohs micrographic surgery for basal cell carcinoma in Singapore: A retrospective review. JAAD Int 17:167\u2013169. https:\/\/doi.org\/10.1016\/j.jdin.2024.07.016","journal-title":"JAAD Int"},{"key":"4274_CR21","doi-asserted-by":"publisher","unstructured":"O\u2019Donnell-Cappelli M, Mandel J, Elder A, Banner L, Nikbakht N (2024) Increased risk of postoperative complications in organ transplant recipients undergoing Mohs micrographic surgery. Dermatologic surgery. Published Online Oct 9. https:\/\/doi.org\/10.1097\/DSS.0000000000004386","DOI":"10.1097\/DSS.0000000000004386"},{"key":"4274_CR22","doi-asserted-by":"publisher","unstructured":"Nguyen TA, Rowe G, Harris K, Ko S, Ko M, Gharavi NM (2022) Antibiotic use and surgical site infections in immunocompromised patients after Mohs micrographic surgery: A Single-Center retrospective study. Dermatol Surg 48(12). https:\/\/doi.org\/10.1097\/DSS.0000000000003620","DOI":"10.1097\/DSS.0000000000003620"},{"key":"4274_CR23","doi-asserted-by":"publisher","unstructured":"Balakirski G, L\u00f6ser CR, Dippel E et al (2020) Surgical site infections after microscopically controlled skin surgery in immunocompromised patients: a retrospective two-center cohort study. Arch Dermatol Res 312(7). https:\/\/doi.org\/10.1007\/s00403-020-02035-8","DOI":"10.1007\/s00403-020-02035-8"},{"key":"4274_CR24","doi-asserted-by":"publisher","unstructured":"Matsumoto A, Li JN, Matsumoto M, Pineider J, Nijhawan RI, Srivastava D (2021) Factors predicting outcomes of patients with high-risk squamous cell carcinoma treated with Mohs micrographic surgery. J Am Acad Dermatol 85(3). https:\/\/doi.org\/10.1016\/j.jaad.2021.01.063","DOI":"10.1016\/j.jaad.2021.01.063"},{"issue":"1","key":"4274_CR25","doi-asserted-by":"publisher","first-page":"01","DOI":"10.13188\/2373-1044.1000036","volume":"5","author":"T Vagdi","year":"2017","unstructured":"Vagdi T, Eilers R, Jiang SIB (2017) Clinical characteristics of Non-Melanoma skin cancers recurring within 5 years after Mohs micrographic surgery: single institution retrospective chart review. J Clin Investig Dermatol 5(1):01\u201304. https:\/\/doi.org\/10.13188\/2373-1044.1000036","journal-title":"J Clin Investig Dermatol"},{"key":"4274_CR26","doi-asserted-by":"publisher","unstructured":"Gonzalez JL, Cunningham K, Silverman R, Madan E, Nguyen BM (2019) Case-Control study of tumor Stage-Dependent outcomes for cutaneous squamous cell carcinoma in immunosuppressed and immunocompetent patients. Dermatol Surg 45(12). https:\/\/doi.org\/10.1097\/DSS.0000000000001930","DOI":"10.1097\/DSS.0000000000001930"},{"key":"4274_CR27","doi-asserted-by":"publisher","unstructured":"McLawhorn JM, Stasko T, Collins L (2021) 27517 Mohs micrographic surgery for high-risk cutaneous squamous cell carcinoma. J Am Acad Dermatol 85(3). https:\/\/doi.org\/10.1016\/j.jaad.2021.06.161","DOI":"10.1016\/j.jaad.2021.06.161"},{"key":"4274_CR28","doi-asserted-by":"publisher","unstructured":"Easwaran TP, Wilke CT, Khaja S (2021) Patterns of failure in immunosuppressed patients with cutaneous squamous cell carcinomas of the head and neck. Int J Radiation Oncology*Biology*Physics 111(3). https:\/\/doi.org\/10.1016\/j.ijrobp.2021.07.1194","DOI":"10.1016\/j.ijrobp.2021.07.1194"},{"key":"4274_CR29","doi-asserted-by":"publisher","unstructured":"Mehrany K, Weenig RH, Pittelkow MR, Roenigk RK, Otley CC (2005) High recurrence rates of squamous cell carcinoma after Mohs\u2019 surgery in patients with chronic lymphocytic leukemia. Dermatol Surg 31(1). https:\/\/doi.org\/10.1097\/00042728-200501000-00008","DOI":"10.1097\/00042728-200501000-00008"},{"key":"4274_CR30","doi-asserted-by":"publisher","unstructured":"Mehrany K, Weenig RH, Pittelkow MR, Roenigk RK, Otley CC (2004) High recurrence rates of basal cell carcinoma after Mohs surgery in patients with chronic lymphocytic leukemia. Arch Dermatol 140(8). https:\/\/doi.org\/10.1001\/archderm.140.8.985","DOI":"10.1001\/archderm.140.8.985"},{"key":"4274_CR31","doi-asserted-by":"publisher","unstructured":"Matsumoto AJ, Schmitt AR, Skelley LM, Baum CL (2018) Factors influencing squamous cell carcinoma in situ recurrence and implications for treatment choice. Dermatol Surg 44(5). https:\/\/doi.org\/10.1097\/DSS.0000000000001400","DOI":"10.1097\/DSS.0000000000001400"},{"key":"4274_CR32","doi-asserted-by":"publisher","unstructured":"Xiong DD, Beal BT, Varra V et al (2020) Outcomes in intermediate-risk squamous cell carcinomas treated with Mohs micrographic surgery compared with wide local excision. J Am Acad Dermatol 82(5). https:\/\/doi.org\/10.1016\/j.jaad.2019.12.049","DOI":"10.1016\/j.jaad.2019.12.049"},{"key":"4274_CR33","doi-asserted-by":"publisher","unstructured":"Rowe DE, Carroll RJ, Day CL (1992) Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: implications for treatment modality selection. J Am Acad Dermatol 26(6). https:\/\/doi.org\/10.1016\/0190-9622(92)70144-5","DOI":"10.1016\/0190-9622(92)70144-5"},{"key":"4274_CR34","doi-asserted-by":"publisher","unstructured":"Nadir U, Le K, Shi K, Srivastava D, Nijhawan RI (2023) Outcomes of squamous cell carcinoma of the lip treated with Mohs micrographic surgery: A retrospective cohort study. Dermatol Surg 49(12). https:\/\/doi.org\/10.1097\/DSS.0000000000003992","DOI":"10.1097\/DSS.0000000000003992"},{"key":"4274_CR35","doi-asserted-by":"publisher","unstructured":"Walker TD, Liao YT, Nikahd M, Hyer M, Shahwan KT, Carr DR (2024) Cutaneous squamous cell carcinoma outcomes in solid organ transplant recipients: A matched retrospective cohort study. Dermatol Surg 50(5). https:\/\/doi.org\/10.1097\/DSS.0000000000004125","DOI":"10.1097\/DSS.0000000000004125"},{"key":"4274_CR36","doi-asserted-by":"publisher","unstructured":"Mi\u00f1ano Medrano R, L\u00f3pez Estebaranz JL, Sanmartin-Jim\u00e9nez O et al (2022) Risk of a second skin Cancer in a cohort of patients with nonmelanoma skin Cancer\u2013Basal cell carcinoma or squamous cell carcinoma-Treated with Mohs micrographic surgery: A National prospective cohort study. Actas Dermosifiliogr 113(5). https:\/\/doi.org\/10.1016\/j.ad.2022.01.003","DOI":"10.1016\/j.ad.2022.01.003"},{"key":"4274_CR37","doi-asserted-by":"publisher","unstructured":"Thompson AK, Kelley BF, Prokop LJ, Murad MH, Baum CL (2016) Risk factors for cutaneous squamous cell carcinoma recurrence,metastasis, and disease-specific death: A systematic review and meta-analysis. JAMA Dermatol 152(4). https:\/\/doi.org\/10.1001\/jamadermatol.2015.4994","DOI":"10.1001\/jamadermatol.2015.4994"},{"key":"4274_CR38","doi-asserted-by":"publisher","unstructured":"Lopez A, Babadzhanov M, Cheraghlou S et al (2023) Immunosuppressed patients are at increased risk of local recurrence, metastasis, and disease specific death from cutaneous squamous cell carcinoma. Arch Dermatol Res 315(5). https:\/\/doi.org\/10.1007\/s00403-022-02458-5","DOI":"10.1007\/s00403-022-02458-5"},{"key":"4274_CR39","doi-asserted-by":"publisher","unstructured":"Manyam BV, Gastman B, Zhang AY et al (2015) Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy. J Am Acad Dermatol 73(2). https:\/\/doi.org\/10.1016\/j.jaad.2015.04.037","DOI":"10.1016\/j.jaad.2015.04.037"},{"key":"4274_CR40","doi-asserted-by":"publisher","unstructured":"Plampton K, Wackel M, Georgesen C et al (2023) 43203 Cutaneous squamous cell carcinoma is associated with lower overall survival in solid organ transplant patients: a matched case-control study. J Am Acad Dermatol 89(3). https:\/\/doi.org\/10.1016\/j.jaad.2023.07.580","DOI":"10.1016\/j.jaad.2023.07.580"},{"key":"4274_CR41","doi-asserted-by":"publisher","unstructured":"Brin L, Zubair AS, Brewer JD (2014) Optimal management of skin cancer in immunosuppressed patients. Am J Clin Dermatol 15(4). https:\/\/doi.org\/10.1007\/s40257-014-0085-5","DOI":"10.1007\/s40257-014-0085-5"},{"key":"4274_CR42","doi-asserted-by":"publisher","unstructured":"Manyam BV, Garsa AA, Chin RI et al (2017) A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck. Cancer 123(11). https:\/\/doi.org\/10.1002\/cncr.30601","DOI":"10.1002\/cncr.30601"},{"key":"4274_CR43","doi-asserted-by":"publisher","unstructured":"Varra V, Woody NM, Reddy C et al (2018) Suboptimal outcomes in cutaneous squamous cell cancer of the head and neck with nodal metastases. Anticancer Res 38(10). https:\/\/doi.org\/10.21873\/anticanres.12923","DOI":"10.21873\/anticanres.12923"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04274-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-025-04274-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04274-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T13:24:12Z","timestamp":1747401852000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-025-04274-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4274"],"URL":"https:\/\/doi.org\/10.1007\/s00403-025-04274-z","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,16]]},"assertion":[{"value":"30 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}},{"value":"Not required","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"IRB status"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"762"}}